It may be one of the most controversial topics in the world.

But there’s no denying the sizable opportunities that cannabis investing is providing. Especially as it just begins to transform multi-billion-dollar industries.

We’re talking about beverages, alcohol, beer, sports drinks, pharmaceuticals, tobacco, and the $3.2 trillion wellness industry, as the cultural renaissance just gets underway.

All thanks to growing acceptance following Canada’s October 2018 legalization, broad approval for its recreational and medicinal use throughout the U.S., and corporate interest.

It’s just starting to disrupt countless, multi-billion-dollar industries.

The medical community is studying it for a variety of ailments — pain, nausea, loss of appetite, Parkinson’s disease, inflammatory bowel disease, post-traumatic stress disorder, epilepsy, and multiple sclerosis and even traumatic brain injuries – the list goes on.

Cigarette maker Altria (NYSE:MO) just took a 45% stake in Cronos Group, as it diversifies business, as cigarette smoking falls to its lowest point in history.

Alcohol companies like Constellation Brands invested $4 billion in Canopy Growth.

Stocks like Green Growth Brands may benefit, too, as a retailer of cannabis and CBD products.  In fact, it’ll soon market its hemp-derived CBD personal care products shortly.

Even the wellness industry sees the opportunity.

The healing properties of marijuana are why spa, wellness and skincare industries are introducing a range of products with cannabis as a key ingredient.

According to an A.T. Kearney consumer survey, 80% of respondents believe cannabis products can offer wellness or therapeutic benefits.  Up to 43% would try therapeutic or supplemental cannabis-infused products.  In addition, the survey found that food, vitamins, skincare products and non-alcoholic beverages were the most favored.

With baby boomers – who make up 70% of wellness industry consumers – seeking alternatives to help improve their quality of life as they age, and younger generations more open to adding cannabis products to their health and wellness regimens, it’s only natural that the global cannabis and wellness markets would converge in a huge way.

Along the way, it’s opening a ground-floor opportunity for investors in related stocks.

Again, it may be one of the most controversial topics for many of us. Still, there’s no denying its potential impact on major industries, and perhaps your stock portfolio.


Leave a Reply

Your email address will not be published. Required fields are marked *

You May Also Like

Federal Health Agencies Think Marijuana From Dispensaries Should Be Tested
11 September 2019
This is What Hexo’s CEO Said About Company’s Dismal Third Quarter
14 June 2021
Both NY’s Senate and Assembly Include Marijuana Legislation in Budget Proposals
15 March 2019